Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Abbott at ESC 2015: Absorb Now Standing Up Against Xience, But Time To Shine Would Come Later

This article was originally published in Clinica

Executive Summary

Data from two separate clinical trials pitting Abbott’s Absorb bioresorbable heart stent against the company’s Xience everolimus drug-eluting stent have shown comparable clinical outcomes for both technologies. But these are still early days, and the real benefits of Absorb will only be known over the longer term.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT102834

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

All set! This Question has been sent to my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel